Inauhzin

Inauhzin is an inhibitor of Sirtuins and p53 used in studies of Apoptosis and Epigenetic Regulation. It is especially relevant in aging, cancer, and cell cycle models, where defined compound exposure can be linked to caspase-associated cell-death signaling and survival decisions and chromatin-state control, histone modification, and transcriptional regulation.

By inhibiting Sirtuins and p53, Inauhzin can be used to examine caspase-associated cell-death signaling and survival decisions and chromatin-state control, histone modification, and transcriptional regulation. The epigenetic regulator annotation adds relevance to chromatin, epigenetic, and gene-expression profiling, together with downstream-response mapping in the same experimental setting. In aging, cancer, and cell cycle models, these readouts can be combined with viability, reporter, localization, biochemical conversion, or morphology endpoints to refine experimental interpretation.

Research Applications

• Target-focused assays involving Sirtuins and p53
• Pathway perturbation studies connected to Apoptosis and Epigenetic Regulation
• Concentration-response inhibition and target-dependence studies
• Chromatin, epigenetic, and gene-expression profiling

Overall, Inauhzin is appropriate when a defined chemical perturbant is needed to connect Sirtuins and p53 with measurable biochemical, transcriptional, electrophysiological, imaging, or phenotypic readouts in aging, cancer, and cell cycle models. This profile is suited to mechanistic follow-up, comparative profiling, and assay optimization under defined exposure conditions.